FDA Announces Public Meeting to Discuss Listeria Risk Assessment and Management Plan

Summary

The Food and Drug Administration (FDA) is hosting a public meeting to present the results of a quantitative risk assessment on the relative risk of foodborne Listeria monocytogenes in ready-to-eat foods, as well as an updated risk management action plan, and to address questions from stakeholders.